India-US trade deal promises policy clarity, fuels Indian pharma’s US growth

NEW DELHI: Domestic drugmakers are set to gain clarity under the proposed India-US trade agreement, sharpening expansion plans in the world’s most lucrative pharmaceutical market. While the sector was insulated from punitive US tariffs, the generics business of major companies including Sun Pharma, Dr Reddy’s and Cipla faced significant headwinds in the third quarter ended…

Read More

India-US trade deal: Top stocks that will benefit from reduced 18% tariffs – check sector-wise list

Stocks that will benefit from India-US trade deal (AI image) India-US trade deal impact on stock market: Reversal of FII outflow, rupee recovering lost ground, general improvement in sentiments towards Indian equities,) return of confidence for FDI, and retracement of India’s underperformance vs. EM peers, etc – these are some of the potential major benefits…

Read More